STOCK TITAN

Nasdaq warns Longeveron (NASDAQ: LGVN) on $1 minimum bid, delisting risk

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Longeveron Inc. reported that Nasdaq has notified the company its Class A common stock no longer meets the $1.00 minimum bid price requirement for listing on The Nasdaq Capital Market, based on the stock closing below this level for 30 consecutive business days. The notice does not immediately remove the stock from Nasdaq.

Longeveron has until March 23, 2026 to regain compliance, which would occur if the bid price closes at $1.00 or more for at least 10 consecutive business days, subject to Nasdaq’s discretion to require up to 20 days. If the closing bid price is $0.10 or less for ten consecutive trading days, Nasdaq may move to suspend and delist the stock sooner. The company plans to monitor its share price and consider options to regain compliance but warns there is no assurance it will succeed or meet other Nasdaq listing rules.

Positive

  • None.

Negative

  • Nasdaq minimum bid-price deficiency and delisting risk: Longeveron’s stock has failed the $1.00 bid requirement, faces a March 23, 2026 compliance deadline, and could be suspended and delisted sooner if the bid stays at or below $0.10 for ten consecutive trading days.

Insights

Nasdaq minimum bid-price deficiency introduces clear delisting risk for Longeveron.

Longeveron Inc. has fallen out of compliance with Nasdaq’s $1.00 minimum bid price rule after 30 consecutive business days below that level. Nasdaq has given the company until March 23, 2026 to bring its Class A common stock bid back to at least $1.00 for a minimum of ten consecutive business days, with the exchange able to extend that streak requirement to 20 days.

The disclosure also highlights a sharper trigger: if the closing bid is $0.10 or less for ten straight trading days before the compliance deadline, Nasdaq may issue a Staff Determination Letter that can lead to immediate suspension and delisting unless appealed. This creates a two-tier risk structure, where deeper price weakness accelerates potential removal from the market.

If Longeveron does not regain compliance by the initial deadline, it may qualify for an additional 180-day period if it meets all other initial listing standards and notifies Nasdaq of its plan to cure the price deficiency. The company states it will monitor its bid price and consider options to remain listed, but also cautions there is no assurance it can satisfy the minimum bid or broader Nasdaq rules, leaving the ultimate outcome dependent on future trading levels and corporate actions.

false 0001721484 0001721484 2025-09-22 2025-09-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 22, 2025

 

Longeveron Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40060   47-2174146

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

1951 NW 7th Avenue, Suite 520

Miami, Florida 33136

(Address of Principal Executive Offices)

 

Registrant’s Telephone Number, Including Area Code: (305) 909-0840

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Stock, $0.001 par value per share   LGVN   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 

 

 

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On September 22, 2025, Longeveron Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) that the Company’s Class A common stock (“Common Stock”) did not meet the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) as a result of the closing bid price of the Company’s Common Stock for the last 30 consecutive business days. The Notice does not result in the immediate delisting of the Company’s Common Stock and, pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has an initial period of 180 calendar days, or until March 23, 2026 (the “Compliance Date”), to regain compliance with the Minimum Bid Price Requirement.

 

If, at any time before the Compliance Date, the bid price closes at $1.00 or more per share for a minimum of ten consecutive business days (subject to Nasdaq’s discretion to increase the minimum period to up to 20 consecutive business days pursuant to Nasdaq Listing Rule 5810(c)(3)(H)), Nasdaq would provide written notification to the Company that it again complies with the Minimum Bid Price Requirement and the Common Stock will continue to be eligible for listing on The Nasdaq Capital Market unless other eligibility deficiencies exist. However, pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(iii), if the Company’s Common Stock has a closing bid price of $0.10 or less for ten consecutive trading days before the Compliance Date, Nasdaq can issue a Staff Determination Letter, which, unless appealed, would subject our Common Stock to immediate suspension and delisting.

 

If the Company does not regain compliance with the Minimum Bid Price Requirement by the Compliance Date, the Company could be eligible for an additional 180 calendar day compliance period. To qualify, the Company would be required to meet the continued listing requirements for the market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and would need to provide written notice to Nasdaq of its intention to cure the deficiency during the additional compliance period.

 

The Company intends to monitor the closing bid price of the Common Stock and assess its available options to regain compliance with the Minimum Bid Price Requirement and continue listing on The Nasdaq Capital Market. There can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement or will otherwise be in compliance with other applicable Nasdaq listing rules.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Current Report on Form 8-K contains forward-looking statements. Any statements about the Company’s expectations, beliefs, plans, predictions, forecasts, objectives, assumptions, or future events or performance are not historical facts and may be forward-looking. These statements are often, but not always, made through the use of words or phrases such as “anticipates,” “believes,” “can,” “could,” “may,” “predicts,” “potential,” “should,” “will,” “estimate,” “plans,” “projects,” “continuing,” “ongoing,” “expects,” “intends,” and similar words or phrases.

 

Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, these statements are not guarantees of future performance and involve risks and uncertainties which are subject to change based on various important factors, some of which are beyond the Company’s control. The Company has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its business, financial condition and results of operations. These forward-looking statements speak only as of the date of this Current Report on Form 8-K and are subject to a number of risks, uncertainties and assumptions including, without limitation, risks and factors that are described in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the Company’s Quarterly Reports on Form 10-Q, which are on file with the SEC and available on the SEC’s website at www.sec.gov. The Company does not undertake any obligation to update any forward-looking statements made in this Current Report on Form 8-K as a result of new information, future events or otherwise.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  LONGEVERON INC.
   
Date: September 26, 2025 /s/ Lisa A. Locklear
  Name:  Lisa A. Locklear
  Title: Chief Financial Officer

 

 

2

 

FAQ

What did Longeveron Inc. (LGVN) disclose in this 8-K filing?

Longeveron Inc. disclosed that Nasdaq notified the company its Class A common stock no longer meets the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market after 30 consecutive business days below that level.

What is the deadline for Longeveron (LGVN) to regain Nasdaq bid-price compliance?

Longeveron has until March 23, 2026 to regain compliance by achieving a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days, subject to Nasdaq’s discretion to require up to 20 days.

Does the Nasdaq notice immediately delist Longeveron’s common stock?

No. The company states that the Nasdaq notice does not result in immediate delisting. The stock remains listed on The Nasdaq Capital Market while Longeveron works within the compliance period and any potential extension.

Under what conditions could Longeveron (LGVN) be suspended and delisted sooner?

If Longeveron’s Class A common stock has a closing bid price of $0.10 or less for ten consecutive trading days before the compliance date, Nasdaq may issue a Staff Determination Letter that, unless appealed, would subject the stock to immediate suspension and delisting.

Can Longeveron receive more time beyond March 23, 2026 to meet Nasdaq’s bid-price rule?

Yes. The filing states Longeveron could qualify for an additional 180-day compliance period if it meets all other initial listing standards for The Nasdaq Capital Market (other than the minimum bid price) and notifies Nasdaq of its intent to cure the deficiency.

How does Longeveron plan to address the Nasdaq minimum bid-price issue?

Longeveron indicates it intends to monitor the closing bid price of its common stock and assess available options to regain compliance with the minimum bid-price requirement, while cautioning there is no assurance it will succeed or satisfy other Nasdaq listing rules.
Longeveron Inc

NASDAQ:LGVN

LGVN Rankings

LGVN Latest News

LGVN Latest SEC Filings

LGVN Stock Data

11.43M
16.90M
14.83%
6.96%
5.26%
Biotechnology
Pharmaceutical Preparations
Link
United States
MIAMI